I have pasted the following report on a recent study on the differences in Auto Adjusting machines.
Once again it highlights the differences in the algorithims used, something I have always suspected. After all any machine will only do what it is instructed to do and as the cpap manufacturers are still undecided on which route to go either individually or as a group it is the poor OSA sufferer who must put up with the problems.
I am aware that many of the 'old school' of sleep specialists are not in favour of prescribing these machines despite the ongoing sales pressure from the cpap companies.
Only last Friday I called to my DME supplier for some pads for the forehead and on making general enquiries was told that 'a lot of our older customers/patients were still on the standard machines (as distinct from the auto paps), but that they hoped to switch them over gradually'. Here's one who won't be switching until such time as they come up with a standard algorithim.
I'd love to hear some comments, particularly from those of you who use these machines.
Daniel.
CPAP devices for sleep apnea âboth have limitationsâ
Aug 03, 2005 - Results from a study comparing two different devices for automatic continuous positive airway pressure (auto-CPAP) to treat obstructive sleep apnea syndrome (OSAS) show that both have clinical limitations, and further research into this area is needed.
âAuto-CPAP machines differ mainly in algorithms used for respiratory event detection and pressure control,â explain Hai-Bo Shi (Kyushu University, Fukuoka) and colleagues.
âThe auto-CPAP machines operated by novel algorithms are expected to have better performance than the earlier ones in the treatment of OSAS.â
For their study, the researchers compared the therapeutic characteristics of two different auto-CPAP devices â the third generation flow-based (f-APAP) and the second-generation vibration-based (v-APAP) â during an initial night of treatment for OSAS.
They retrospectively reviewed the records of 43 OSAS patients who underwent overnight polysomnography diagnosis to confirm the disease followed by auto-CPAP treatment with either the f-APAP or v-APAP device under a second polysomnography evaluation.
The results, published in the journal Auris Nasus Larynx, showed that 13.6% of patients retained a residual apnea/hypopnea index of more than 5 during f-APAP therapy, compared with 61.9% of those who underwent v-APAP.
Furthermore, the researchers found that the f-APAP was more effective than the v-APAP at reducing the patientsâ apnea/hypopnea index, hypopnea index, and apnea index, as well as at improving the lowest oxygen saturation index and shortening stage 1 sleep.
In contrast, however, the v-APAP was more effective at reducing the patientsâ arousal/awakening index.
âIn conclusion, flow-based auto-CPAP works better than vibration-based one in abolishing nocturnal respiratory events and improving the lowest SaO2. However, the latter is more effective than the former in reducing sleep fragmentation,â summarize Shi et al.
âTherefore, even in devices that generally work well, they still have some principal limitations. â
They add that âfurther studies are needed, importantly, to evaluate the efficacy of long-term use of auto-CPAP therapy for OSAS.â
Auris Nasus Larynx 2005; 32: 237â241
Journal

